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Abstract
It is becoming clear that inflammation plays a significant role in a number of neurological and psychiatric conditions. Post
mortem brain samples in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis,
schizophrenia and most recently autism spectrum condition, all exhibit neuroglial activation and inflammatory markers
within the CSF. Many questions remain about the underlying molecular mechanisms. By adding the pro-inflammatory
cytokine, TNF-a, to mouse brain tissue we demonstrated that the frontal lobes and temporal region, areas involved in higher
functions such as memory and learning, are most susceptible to cytokine-induced inflammation via the NF-kB signalling
pathway. We observed direct correlations between the volumetric increase and molecular expression indicating that
therapeutic targets in these lobes may require different approaches when treating conditions with a central
neuroinflammatory component.
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Introduction
Inflammation potentially plays a major role in a number of
neurological and psychiatric conditions. Direct evidence for an
innate inflammatory response has been demonstrated in Alzhei-
mer’s disease (AD) [1], Parkinson’s disease (PD) [2], multiple
sclerosis (MS) [3], amyotrophic lateral sclerosis (ALS) [3],
schizophrenia [4] and most recently autism spectrum condition
(ASC) [5–9]. Although affecting different areas, a common theme
is the specificity of the inflammation, in that it is confined to
certain brain regions rather than a generalised effect.
Nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-kB) is a family of proteins that control the transcription of
DNA. It induces the expression of inflammatory cytokines and
chemokines and, in turn, is induced by them [10,11]. This
establishes a positive feedback mechanism [12], which has the
potential, when NF-kB becomes aberrantly active, to produce the
chronic or excessive inflammation associated with several inflam-
matory diseases [9]. Furthermore, post mortem studies suggest
that the transcription factor plays a key role in many conditions
[1–4,13].
Our evaluation of this process, reported here, was targeted
towards the innate immune system and the activation of the
classical pathway using tumour necrosis factor-a (TNF-a). It is well
established that the classical NF-kB intracellular signally pathway
for innate inflammatory response is based on IkB kinase (IKK)
degradation by activated IKKb (inhibitor of nuclear factor kappa-
B kinase subunit beta) liberating NF-kB and allowing translocation
to the nucleus where it activates the genes involved in immune
responses [14].
In greater detail, the activation and nuclear translocation of NF-
kB dimers (mainly p50–p65) is associated with increased
transcription of genes encoding chemokines, cytokines, adhesion
molecules (intercellular adhesion molecule-1, vascular cell adhe-
sion molecule-1 and endothelial–leukocyte adhesion molecule-1),
and enzymes that produce secondary inflammatory mediators and
inhibitors of apoptosis [11]. The activation of such signalling
pathways leads to translocation of NF-kB dimers from the
cytoplasm to the nucleus [9,10]. Proinflammatory cytokines and
pathogen-associated molecular patterns, working through different
receptors belonging to the tumor necrosis factor receptor and Toll-
like receptor, interleukin-1 receptor superfamilies, cause activation
of the IkB kinase (IKK) complex [11]. The most common form of
this complex consists of the IKKa and IKKb catalytic subunits
and the IKKc regulatory subunit. Like NF-kB proteins IKKa and
IKKb undergo homo- and hetero-dimerization. In the classical
NF-kB signalling pathway, the activated IKK complex, predom-
inantly acting through IKKb in an IKKc-dependent manner,
catalyzes the phosphorylation of IkBs (at sites equivalent to Ser32
and Ser36 of IkBa), polyubiquitination (at sites equivalent to
Lys21 and Lys22 of IkBa) and subsequent degradation by the 26S
proteasome [15]. The released NF-kB dimers (in this pathway,
most commonly the p50–p65 dimer) translocate to the nucleus,
bind DNA and activate gene transcription [15]. Deficiencies in
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NF-kB p65 and IKKb result in a marked increase in susceptibility
of the organism to infections, once the embryonic lethality
associated with these deficiencies is prevented [16–17].
In this current study we have addressed the question as to
whether three distinctly different regions of the murine brain that
are known to be affected by inflammatory brain disease to
different extents respond to cytokine induced inflammation, and
whether this correlates with NF-kB expression. In doing so we
applied a novel pressure chamber system to assess the differential
inflammatory response of cortical lobes based on volume as well as
traditional histological analysis.
Materials and Methods
This study was carried out in strict accordance with United
Kingdom Home Office guidelines on the Care and Use of
Laboratory Animals. The protocol was approved by the
University Teaching and Research Ethics Committee (UTREC)
of the University of St Andrews (Reference Number: MD4637).
No experimental procedures were performed on live animals. All
animals were sacrificed by schedule 1 cervical dislocation by
trained personnel, and all efforts were made to minimize
suffering.
Primary neurons were stimulated with TNF-a to measure NF-
kB expression using immunofluorescence and immunoblotting
techniques in order to gain an impression of the molecular
response in vitro. This response was then measured in vivo to
observe the contrast in NF-kB expression between the two
preparations and as such the novelty of our model in assessing
inflammation in whole tissue. Upon recognition that the NF-kB
response was significantly different in the three lobes measured we
then measured the volumetric change in these areas and assessed
the potential association with the transcription factor.
Primary neuron culture and stimulation with TNF-a
Pregnant time-mated CD1 mice were sacrificed by schedule 1
cervical dislocation after 14 days gestation and the cortices
dissected from the embryos, under sterile conditions as described
by Oldreive et al., [18]. The tissue was trypsinised and a single cell
suspension plated on 0.001% (w/v) polylysinecoated 6-well plates
(Nunc) in MEM supplemented with 10% horse serum and 10%
fetal calf serum (FCS). After 24 hours the medium was switched to
MEM supplemented with serum replacement 2 (Sigma, UK) and
18 mM 5-fluorodeoxyuridine to inhibit the proliferation of non-
neuronal cells. Primary cortical neuron cultures (.99% pure) were
incubated for a further 18 hours and stimulated with 10 ng/ml
TNF-a for 2 hours before antigen positive cells were counted in
each sample to quantify the intensity of anti-p65 signal in the
nucleus, providing a measurement of nuclear translocation of NF-
kB p65 and thus the active state of the molecule.
Western Immunodetection of primary neurons
Protein samples run on SDS-polyacrylamide gels were electro-
blotted to nitrocellulose membranes (Schleicher & Schuell,
Germany), blocked with 5% non-fat dry milk in PBS with 0.1%
Tween 20 (PBST) and probed with a 1:1000 dilution of anti-p65
antibody (Santa Cruz Biotechnology). PBST washed membranes
were then incubated with HRP-conjugated goat anti-rabbit
antisera (Sigma, UK), and developed with enhanced chemilumi-
nescence reagents (Pierce, UK). Signal was detected using a LAS
3000 image analyzer (Fujifilm, Japan) and bands quantified using
ImageJ software.
Isolation of tissue cultures
Adult CD1 mice (33–40 g) were sacrificed by schedule
1 cervical dislocation as above. Brains were extracted and
dissected according to Hagihara et al., [19] to provide cerebellum,
hippocampus with associated cortex (temporal region) and frontal
lobe preparations. These were allowed to recover for 3 hours in
5% heat inactivated foetal calf serum (FCS) in RPMI 1640 me-
dium (Gibco, UK) at 37uC, and thereafter stimulated with 10 ng/
ml TNF-a (R&D Systems, UK) [20]. For individual cell
preparations 3 mm3 of tissue was mechanically disrupted and
trypsinised (Sigma, UK) for 10 minutes to provide a single cell
suspension. RPMI 1640 medium with 5% FCS was added to
inhibit trypsin activity. Isolated cells were stimulated with 10 ng/
ml TNF-a for up to 4 hours and 96 hours in separate
preparations. For inhibition studies, 1 mg/ml IKK Inhibitor
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or 150 mg/ml
sodium salicylate (Santa Cruz Biotechnology) were added.
Dissociation of cytosolic and nuclear material
Tissue samples were processed for nuclear and cytosolic
extraction using two separation buffers. The tissue was homoge-
nized in 10 volumes of buffer 1 (Tris 10 mM, NaH2PO4 20 mM,
EDTA 1 mM, pH 7.8 PMSF 0.1 mM, pepstatin 10 mg/ml, and
leupeptin 10 mg/ml). Homogenate was incubated for 20 min and
osmolarity restored by adding 1/20 volume of KCl 2.4 M, 1/
Table 1. Procedural details of volumetric measurements.
Step 1: Dissection of mouse brain in ventilated hood
Step 2: Fill a standard test tube with 15ml of RPMI 1640 medium with 5% FCS at 37uC
Step 3: Calibrate vertically-mounted travelling microscope to the meniscus
Step 4: Place brain tissue into test tube to displace fluid
Step 5: Measure the displaced volume by calibrating the travelling microscope to the new height of the meniscus
Step 6: Remove the brain tissue and place in a single well plate containing RPMI 1640 medium with 5% FCS at 37uC at leave to rest in the incubator for 1 hour.
Step 7: Add solution to dish and cover with sterile parafilm.
Step 8: Peirce parafilm with a pre-autoclaved capillary tube.
Step 9: Fluid will displace up the tube, allow to settle and mark the outside of the capillary.
Step 10: Place in incubator for a set time and mark the new fluid height. This can be continued repeatedly over multiple time points.
Step 11: Knowledge of the length fluid has travelled over a set time will allow calculation of displaced volume. This can now be presented as a percentage increase of
initial mass.
doi:10.1371/journal.pone.0039049.t001
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40 volume of NaCl 1.2 M, 1/5 volume sucrose 1.25 M. Samples
were spun for 5 min at 3,500 rpm, supernatant removed and
pellet resuspended on 0.6 M sucrose and spun for a further 10 min
at 10,000 rpm.
Subsequently, the supernatant was diluted in buffer 2 (imidazole
30 mM, KCl 120 mM, NaCl 30 mM, NaH2PO4, sucrose
250 mM pH 6.8, protease inhibitors pepstatin 10 mg/ml and
leupeptin 10 mg/ml) and spun again at 3,500 rpm for 15 min. The
resultant pellets contained the remaining nuclear proteins, and the
supernatants the cytosolic proteins.
Immunofluorescence microscopy and Western
Immunodetection of tissue cultures
A 3 mm3 volume of tissue was mechanically dissociated and fixed
in 4% formaldehyde in PBS. Cells were stained with anti-Beta III
Tubulin (1:10,000), a microtubule element antibody targeted
exclusively in neurons, and anti-p65 antibody (1:50 dilution) in
buffer containing 0.2% saponin for 60 minutes. Samples were then
washed and incubated with FITC & Texas Red labelled second
stage. This was followed by a final 5 minute wash and slides were
mounted with 49,6-diamidino-2-phenylindole (DAPI) with Vecta-
shield (Vector Labs Ltd, UK) to identify cell nuclei.
One hundred neurons from each sample were selected from 10
visual fields covering the full area of the tissue slice within each of
which 10 neurons were selected at random, blinded from group
(i.e., control or TNF-a stimulated). Antigen positive cells were
counted in each sample using the rating scale of Schmidt and
Bankole [21], to quantify the intensity of anti-p65 signal in the
nucleus providing a measurement of nuclear translocation of NF-
kB p65 and thus the active state of the molecule. Each cell was
given a rating of fluorescence from 0 (negative) to 3+ (most
intense). A fluorescence scale of 3+ was calibrated on the intense
green fluorescence exhibited by NF-kB antigen in HeLa cell
controls. Scoring was verified by image J analysis.
Western Immunodetection was performed as described previ-
ously.
Volume measurements and Pressure chamber
Brain volumes were measured using a vertically-mounted
travelling microscope to measure the height of liquid in a 15 ml
test tube displaced by the addition of brain tissue.
For Pressure Chamber experiments tissue was added to a
single well plate containing RPMI 1640 medium with 5% FCS
at 37uC with or without 10 ng/ml TNF-a for up to 96 hours.
Wells were sealed with parafilm and pierced with a capillary
Figure 1. Immunofluorescent staining of primary cortical neurons. A: p65 expression in primary cortical neurons, showing increased
expression with TNF-a and decreased expression with IKK Inhibitor (F = 177.79; p,0.001; df = 2,12). B: NF-k B expression in a control neuron, using
anti-p65 antibody and FITC labelled secondary, NF-k B expression in a TNF-a stimulated neuron and NF-k B expression in a TNF-a stimulated neuron
with NF-k B inhibitor. C: The percentage of neurons with anti-p65 staining in the nucleus (F = 30.63; p,0.001; df = 2,14), and D: the levels of
fluorescence in each sample where fluorescence is rated between 0 and 3 on the scale bar (F = 17.65; p,0.002; df = 2,57). Molecular weight markers
are in kilodaltons (kDa).
doi:10.1371/journal.pone.0039049.g001
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tube. The volume of fluid in the capillary was calculated from
the height rise and the diameter of the capillary tube.
Measurements were normalised as a percentage of the initial
volume. Inflammation of the tissue was confirmed by hematox-
ylin and eosin (H&E) staining and observation of cell morphol-
ogy. Full details are given in Table 1.
Statistics
Statistical testing was performed with Analysis of Variance and
Tukey-Kramer procedure for multiple comparisons using Sigma
Plot 5. Data was considered significant at p,0.05. Data was
checked for normal distribution using the K-sample Anderson–
Darling test. Unless indicated, all data are expressed as mean 6
standard error across the samples.
Results
TNF-a induces p65 translocation in primary neuron
cultures
Primary cortical neuronal cultures were studied to calibrate the
response to stimulation with 10 ng/ml TNF-a and inhibition with
1 mg/ml IKK. Whole cell NF-kB expression analysis was
performed by immunoblotting with primary neurons stimulated
with TNF-a demonstrating a 2-fold increase in NF-kB expression
(figure 1A; F= 177.79; p,0.001; df = 2,12). After stimulation with
TNF-a there was increased NF-kB p65 nuclear localisation when
compared to untreated cultures (figure 1B–C; F= 30.63; p,0.001;
df = 2,12, figure 1D; F= 17.65; p,0.002; df = 2,57).
IKK inhibitor prevented TNF-a mediated p65 nuclear trans-
location when cultures were exposed to both simultaneously. Due
to the strong inhibitory properties of IKK inhibitor we also
examined its potential to reverse inflammation. TNF-a stimulated
primary neurons were washed and further stimulated with TNF-a
with or without IKK Inhibitor. Although NF-kB effectively
translocated to the nucleus in the first 2 hour period, after the
wash out IKK inhibitor returned nuclear NF-kB values back to
that previously observed (data not shown).
TNF-a induces differential NF-kB expression and nuclear
localisation in different brain regions
Having established nuclear translocation of NF-kB in neuronal
clusters we next examined, by immunoblotting, whether levels of
the NF-kB p65 following TNF-a stimulation of whole brain tissue
sections were dependent on location.
NF-kB p65 was upregulated with time, (data significant after 1/
2 hour, figure 2A; F= 8.57; p = 0.012; df = 2,57). Interestingly, the
frontal lobes and temporal region of the brain demonstrated up-
regulated NF-kB p65 to a greater extent in comparison to the
cerebellum. The frontal lobe and temporal region sections
expressed 15-fold and 10-fold more NF-kB p65 respectively,
whereas cerebellum tissue demonstrated only a 6-fold increase.
To confirm the subcellular localization of p65 in our samples we
immunoblotted whole cell, cytoplasmic, and nuclear extracts.
Localization of the transcription factor was mainly within the
nucleus 1 hour after TNF-a stimulation (figure 2B; F= 5.56;
p = 0.043; df = 2,27). We also analysed the translocation of NF-kB
p65 into the nucleus using immunofluorescence of mechanically
dissociated neural tissue using a rating scale based on Schmidt and
Bankole [21] grading p65 fluorescence in the nucleus from 0 to 3,
with the scoring system also being verified by image J analysis.
After 2 hours of stimulation from the one hundred randomly
sampled neurons from each sample, nuclear localization of NF-kB
p65 occurred in 4864% of frontal lobe neurons compared to
2863% in controls, 3663% of temporal region neurons
Figure 2. Western Blot analysis of p65 subunit of NF-kB. A: NF-
kB p65 expression after stimulation with TNF-a for 0, 0.5, 1 and 2 hours.
Frontal lobe (Front), Temporal region (Temp) and Cerebellum were
examined (F = 8.57; p = 0.012; df = 2,57). B: Western Blot analysis of p65
subunit of NF-kB nuclear vs. cytoplasmic analysis after 1 hour of TNF-a
stimulation, comparing whole cell expression (WC) to nucleus (Nuc) and
cytoplasmic (Cyt) preparations, data is significant after 1 hour of
stimulation (F = 5.56; p = 0.043; df = 2,27). Calibration bars are 10 mm. C:
The percentage of neurons with anti-p65 staining in the nucleus,
comparing in vivo frontal lobe, temporal region and cerebellum
neurons with the aggregate of all cells (F = 20.99; p,0.001; df = 3,36).
Molecular weight markers are in kilodaltons (kDa).
doi:10.1371/journal.pone.0039049.g002
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compared to 1762% of controls, and 2263% in cerebellum tissue
compared to 1662% in controls. These results were significantly
lower than in the primary neuron cultures where TNF-a
stimulation induced nuclear localisation in 8867% of cells
compared to 1964% in controls (figure 2C; F= 20.99; p,0.001;
df = 2,36).
NF-kB expression and localisation correlates with brain
tissue inflammation
Using the pressure chamber system and histological investiga-
tion we then sought direct evidence that the spatially varying
distribution of NF-kB expression was related to inflammation.
Tissue was stimulated with 10 ng/ml TNF-a for 2 hours and
then washed to remove TNF-a. Volumetric changes were
measured at 0.5, 1 and 2 hours post-stimulation and at 1 and
2 hours post-washing. Volume change continued to occur
steadily after the removal of the cytokine (figure 3A–C;
F= 22.53; p = 0.001; df = 3,96), indicating an initial short
stimulus triggers the inflammatory response which continues
after the initial stimulus is withdrawn. Volume increases
demonstrated a strong correlation with NF-kB response, the
frontal lobe (figure 3D; r2 = 0.9126; F= 65.25; p = 0.003;
df = 3,96) and temporal region (figure 3E; r2 = 0.9964;
F= 34.96; p= 0.007; df = 3,96) of the brain demonstrated the
greatest increase relative to the cerebellum (figure 3F;
r2 = 0.8608; F= 118.89; p = 0.001; df = 3,96).
Over a 96 hours, stimulation with TNF-a initiated an
inflammatory response that produced a volume increase in excess
of 30% in the whole brain preparations (not shown), with greatest
changes in the sub-dissected frontal lobes and temporal region
preparations (figure 4A–C; F= 816.22; p,0.001; df = 3,99). These
changes corresponded with morphological changes within the
tissue itself. The tissue stimulated TNF-a demonstrating a higher
cellular content, representative of inflammation (figure 4D–F).
This suggests that the frontal lobes and temporal region of the
murine brain appear more susceptible to neuroinflammation in
comparison to the other brain regions studied here.
To determine if NF-kB played a role in this inflammation,
tissues were also stimulated with TNF-a in the presence of 1 mg/
ml IKK Inhibitor or 150 mg/ml sodium salicylate [20]. Both
Figure 3. Quantification of inflammation induced by TNF-a. Tissue inflammation in Control (Ctrl), 10 ng/ml TNF-a (TNF), TNF-a with IKK
Inhibitor (IKK), and TNF-a with sodium salicylate samples (Sodium S). A–C: Measurements at 0.5, 1 and 2 hours stimulation and after TNF-a removal (3
and 4 hours). Results are presented as for figure 1, data is significant after 2 hours of stimulation (F = 22.53; p = 0.001; df = 3,96). D-F: Plot of %
volumetric increase of tissue vs. normalized overall expression of NF-kB p65 from quantification of Western blot samples with a superimposed line of
linear regression.
doi:10.1371/journal.pone.0039049.g003
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IKK Inhibitor and sodium salicylate inhibited the inflammation
of brain tissue in short and long term cultures, implicating IKK/
NF-kB signaling in the inflammation (figure 3&4A–C).
Discussion
NF-kB is found in almost all cells types and plays a significant
role in a major inflammatory pathway. These data confirm that
NF-kB is strongly expressed and translocates to the nucleus of
neurons in culture. A key result in this experiment is that the level
of expression and nuclear translocation of NF-kB is dependent on
the location of neurons in the neocortex or cerebellum. This is
linked to an inflammatory response by volume increases,
histological analysis and, finally, to correlations with NF-kB
expression. This microscopic-to-macroscopic succession of evi-
dence provokes the, to our knowledge, novel conclusion that three
distinctly different areas of the murine brain respond to
inflammatory stimulus to varying degrees.
TNF-a was specifically selected to activate the classical NF-kB
signalling cascade of the innate immune system [14] and to
demonstrate nuclear translocation of NF-kB in primary cortical
neurons. Our main focus was to examine the holistic response to
inflammation in the brain areas described and to justify our model
by comparing the level of molecular expression between in tissue
model and cellular assays. In doing so we observed a significantly
lower level of nuclear translocation in tissue throughout all areas of
the brain demonstrating the importance of analysing NF-kB
expression in cells in tissue assay.
Assessment of NF-kB p65 expression was performed in frontal
cortex, temporal region and cerebellum. Frontal lobe and
temporal region sections appeared to be the most affected (15-
fold and 10-fold more NF-kB p65 respectively) whereas
cerebellar tissue expressed a 6-fold increase. Although it has
been previously recognised by Glass et al [3] that NF-kB
expression is upregulated in the substantia nigra, basal forebrain,
brain stem and spinal cord playing a role in inflammation in PD,
AD and ALS respectively, this experiment shows that it can also
be activated to greater and lesser extents within other neural
structures concurrently by inducing an inflammatory process. In
addition, not only is NF-kB present in aberrant quantities,
nuclear translocation of the p65 subunit suggests that NF-kB is
modulating gene transcription.
Figure 4. Quantification of inflammation induced by TNF-a. Tissue inflammation in Control (Ctrl), 10 ng/ml TNF-a (TNF), TNF-a with IKK
Inhibitor (IKK), and TNF-a with sodium salicylate samples (Sodium S). A–C: Measurements at 24, 48, 72 and 96 hour periods in A: frontal lobe, B:
temporal region, and C: cerebellum. Data is significant after 24 hours of stimulation. Results are presented as a percentage increase of original value
(F = 816.22; p,0.001; df = 3,96). D–F: Confirmation of inflammation with hematoxylin and eosin (H&E) stain. Tissue stimulated with TNF-a 10 ng/ml in
frontal lobe (D), temporal region (E) and cerebellum (F). Calibration bars are 50 mm.
doi:10.1371/journal.pone.0039049.g004
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The explanation for the differential inflammation of brain
regions is most likely to be found in the associations between
microglia density and receptor expression. Whereas microglia are
known to occupy all brain areas, differences in their cellular
density between different brain regions under physiological
conditions can be as high as five-fold in mouse [22]. Microglia
are most numerous in the telencephalon, followed by dienceph-
alon, mesencephalon and rhombencephalon containing the lowest
density of microglia. Nevertheless, where we have observed an
inflammatory susceptibility gradient of frontal lobe . temporal
region . cerebellum, Lawson et al. [22] found that in fact the
hippocampus contained more microglia that the frontal lobe.
From this we deduce that the response we have witnessed is a
result of receptor expression and cell signalling cascades. The
density of microglia at rest has been confirmed to be higher in the
temporal region [23]. However, stimulation of these areas with
lipopolysaccharide (LPS) demonstrated a greater response in the
frontal lobe in keeping with our observations in this experiment.
Whilst possible mechanisms for this effect were not explored, it is
well documented that LPS activates the nuclear translocation of
NF-kB via Toll-like-receptor 4 (TLR4) [24].
A key result is the correlation between NF-kB expression and
tissue volume increase. We observed that the frontal lobe and
temporal region demonstrated the greatest inflammatory response
following TNF-a stimulation. The frontal cortex is primarily
associated with developing personality and regulating appropriate
behaviours by providing an inhibitory function [25] and can be
particularly affected in individuals with neuroinflammatory
conditions [26–29]. In particular NF-kB was observed to be
increased 2.9-fold higher in post-mortem samples from donors
with ASC compared to matched controls [13]. Generally
neuroinflammatory responses have been linked to cognitive
decline [30], memory loss [31] and impairment of co-ordination
[32], as well as psychiatric manifestations [12,33] via the
disruption of neural signalling. However the molecular mechanism
for this inflammation has yet to be defined. We suggest that the
induction of inflammation via the NF-kB signalling cascade is
potentially responsible for localised neuroinflammation in higher
areas of the brain leading to behavioural and clinical symptoms in
a range of disorders.
In conclusion, we have reported a novel in vitro model for
quantifying brain tissue inflammation which allows the study of
inflammatory quantification and correlation with the molecular
pathways involved. We have thus been able to demonstrate the
regional variation of inflammation in the brain and a potential role
for NF-kB. These observations suggest that NF-kB could
contribute a significant role in the inflammatory pathogenesis of
regional disease and raises the question of whether further
consideration of the location of inflammation within the brain
could be used to fine tune anti-inflammatory therapy.
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